This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Diageo (DEO) Launches Crown Royal Ready-to-Drink Product Line
by Zacks Equity Research
Diageo (DEO) launches Crown Royal ready-to-drink canned cocktail line to capitalize on the growing demand for ready-to-drink beverages amid the pandemic.
Helen of Troy (HELE) Poised on Leadership Brands, Online Growth
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, it is likely to keep gaining from consistent online sales.
Coty (COTY) to Team Up With LanzaTech for its Fragrance Business
by Zacks Equity Research
Coty (COTY) intends to partner with LanzaTech to have most of its fragrance portfolio made using carbon-captured ethanol by 2023.
Inter Parfums (IPAR) Q4 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter 2020 sales and earnings rise year over year. Also, management raises 2021 guidance.
Helen of Troy (HELE) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Helen of Troy (HELE) has been struggling lately, but the selling pressure may be coming to an end soon.
Nu Skin (NUS) More Than Double in a Year: Will Momentum Stay?
by Zacks Equity Research
Nu Skin (NUS) is benefiting from initiatives to strengthen sales leader and expand customer base. Also, the company's focus on digital operations is impressive.
Keurig Dr Pepper (KDP) Q4 Earnings Miss Estimates, Sales Beat
by Zacks Equity Research
Robust market share gains and better at-home consumption trends aid Keurig Dr Pepper's (KDP) sales in Q4. Dollar market share improve more than 90% of KDP's cold beverage retail base.
The Estee Lauder (EL) to Raise Stake in DECIEM to Aid Growth
by Zacks Equity Research
The Estee Lauder (EL) will increase its stake in DECIEM from nearly 29% to roughly 76% for almost $1 billion. The deal is likely to be concluded during the quarter ending Jun 30.
4 Factors That Make The Estee Lauder (EL) a Promising Pick
by Zacks Equity Research
The Estee Lauder's (EL) impressive online business is driving growth. Also, the company's Skin Care portfolio is performing well.
Nu Skin (NUS) Tops Q4 Earnings Estimates, Raises Dividend
by Zacks Equity Research
Growth in sales leaders and customer base drove Nu Skin's (NUS) fourth-quarter 2020 results. Notably, earnings and revenues increased year over year.
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
Why Is Helen of Troy (HELE) Up 2.6% Since Last Earnings Report?
by Zacks Equity Research
Helen of Troy (HELE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Estee Lauder (EL) Q2 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2021 sales and earnings increase year over year. However, results reflect impact of some retail store closures and lower traffic in reopened stores amid COVID-19.
Clorox (CLX) Q2 Earnings, Sales Top Estimates on Strong Demand
by Zacks Equity Research
Clorox's (CLX) Q2 sales benefit from double-digit sales growth in the majority of the segments, fueled by strong product demand due to the coronavirus outbreak and related shift in trends.
3 Reasons Growth Investors Will Love Helen of Troy (HELE)
by Zacks Equity Research
Helen of Troy (HELE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks Industry Outlook Highlights: Estee Lauder, Helen of Troy, Coty, Nu Skin Enterprises and e.l.f. Beauty
by Zacks Equity Research
Zacks Industry Outlook Highlights: Estee Lauder, Helen of Troy, Coty, Nu Skin Enterprises and e.l.f. Beauty
Inter Parfums (IPAR) Ups 2020 Earnings View on Solid Q4 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in fourth-quarter 2020. Management raises 2020 earnings guidance.
5 Cosmetics Stocks Looking Good Amid Industry Challenges
by Vrishali Bagree
The Zacks Cosmetics industry is battling coronavirus woes like weak travel retail, reduced traffic and low makeup demand. However, high demand for personal care products bodes well for EL, HELE, COTY, NUS and ELF, which are focused on adapting to the changing market trends.
3 Factors That Makes Helen of Troy (HELE) a Promising Pick
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Also, strength in the company's online business is yielding.
New Strong Buy Stocks for January 15th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Inter Parfums' (IPAR) Subsidiary to Buy Office Building Complex
by Zacks Equity Research
Inter Parfums' (IPAR) subsidiary Interparfums SA to buy property in Paris, which will be used as its headquarters. Management expects to close the transaction during spring of 2021.
Estee Lauder (EL) Looks Solid on Online Business & Savings
by Zacks Equity Research
Estee Lauder (EL) is implementing new technology and digital experiences to boost online sales. Also, strength in the Skin Care category is driving growth.
Helen of Troy's (HELE) Q3 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter fiscal 2021 results reflect strength across the Beauty and the Health & Home segments along with gains in online business.
Helen of Troy (HELE) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 20.90% and 13.43%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Will High Demand & Online Strength Continue to Aid Colgate (CL)?
by Zacks Equity Research
Despite cost and currency-related headwinds, strong product demand and sturdy online show are likely to help Colgate (CL) stay put amid this COVID-19 crisis.